When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TCON - Tracon Pharma up 39% premarket on envafolimab deal
TRACON Pharmaceuticals Inc.
TRACON Pharmaceuticals (NASDAQ:TCON) is up 39% premarket on signing a collaborative partnership agreement with 3D Medicines (Beijing) Co., Ltd. and Jiangsu Alphamab Biopharmaceuticals Co., Ltd., for the development of envafolimab, also known as KN035, a PD-L1 single-domain antibody administered by subcutaneous injection, for development in soft tissue sarcoma in North America.
More news on: TRACON Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,